Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstraße 2, 86156 Augsburg, Germany.
Medicina (Kaunas). 2022 Jan 20;58(2):157. doi: 10.3390/medicina58020157.
Preeclampsia is a pregnancy-specific disease which is characterized by abnormal placentation, endothelial dysfunction, and systemic inflammation. Several studies have shown that the maternal immune system, which is crucial for maintaining the pregnancy by ensuring maternal-fetal-tolerance, is disrupted in preeclamptic patients. Besides different immune cells, immune checkpoint molecules such as the programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1 system) and the T-cell immunoglobulin and mucin domain-containing protein 3/Galectin-9 (TIM-3/Gal-9 system) are key players in upholding the balance between pro-inflammatory and anti-inflammatory signals. Therefore, a clear understanding about the role of these immune checkpoint molecules in preeclampsia is essential. This review discusses the role of these two immune checkpoint systems in pregnancy and their alterations in preeclampsia.
子痫前期是一种妊娠特有的疾病,其特征为胎盘异常、血管内皮功能障碍和全身炎症。多项研究表明,母体免疫系统在维持妊娠中起着至关重要的作用,通过确保母胎耐受来维持妊娠,但子痫前期患者的母体免疫系统被破坏。除了不同的免疫细胞外,免疫检查点分子,如程序性细胞死亡蛋白 1/程序性死亡配体 1(PD-1/PD-L1 系统)和 T 细胞免疫球蛋白和粘蛋白结构域蛋白 3/半乳糖凝集素 9(TIM-3/Gal-9 系统)也是维持促炎和抗炎信号平衡的关键因素。因此,清楚了解这些免疫检查点分子在子痫前期中的作用至关重要。本综述讨论了这两种免疫检查点系统在妊娠中的作用及其在子痫前期中的改变。